)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Traws Pharma
Traws Pharma (TRAW) investor relations material
Traws Pharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 May, 2026
Executive summary
Annual meeting scheduled for July 8, 2026, with voting open until July 7, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by June 24, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of seven directors, with nominees including Iain Dukes, Werner Cautreels, Trafford Clarke, John Leaman, Nikolay Savchuk, M. Teresa Shoemaker, and Jack E. Stover.
Proposal to amend the 2021 Incentive Compensation Plan to increase available shares by 2,000,000 and make administrative changes.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval sought for issuance of common stock upon exercise of Series B and C Warrants issued under a Securities Purchase Agreement dated April 15, 2026.
Proposal to allow adjournment of the meeting if additional proxy solicitation is needed.
Board of directors and corporate governance
Board recommends approval of all proposals presented for shareholder vote.
Director nominees represent a mix of scientific, medical, and executive backgrounds.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Traws Pharma
- Shareholders will vote on directors, plan amendments, auditor ratification, and warrant share issuance.TRAW
Proxy filing29 May 2026 - Virtual meeting to vote on directors, incentive plan, auditor, share issuance, and governance.TRAWProxy filing19 May 2026
- Q1 2026 net loss was $7.1M; up to $60M financing secured, but liquidity concerns persist.TRAWQ1 202615 May 2026
- Registering 35.9M shares for resale, with proceeds from warrants funding clinical development.TRAWRegistration filing8 May 2026
- Returned to profitability in 2025 and secured up to $60M to fund key clinical milestones.TRAWQ4 202516 Apr 2026
- Lead antivirals progress with strong data, new financing, and CEO transition for 2025 milestones.TRAWQ4 2024 & Study Update13 Feb 2026
- $128.1M H1 net loss after merger; cash runway through 2024, key clinical data ahead.TRAWQ2 20241 Feb 2026
- Registering 7.2M shares for resale, with proceeds from warrant exercises funding R&D.TRAWRegistration Filing16 Dec 2025
- 128.9M shares registered for resale post-acquisition; no proceeds to company, material risks disclosed.TRAWRegistration Filing16 Dec 2025
Next Traws Pharma earnings date
Q2 202613 Aug, 2026
Traws Pharma
Next Traws Pharma earnings date
Q2 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage